News
Hong Kong Ferry announces FY2023 annual results Increase in revenue for FY2023 Sales on completed existing units of The Symphonie
Hong Kong Ferry announces FY2023 annual results Increase in revenue for FY2023 Sales on completed existing units of The Symphonie
REKORDRESULTATE FÜR UMSATZ, GELDFLUSS UND BEREINIGTEN EBIT
Ad-Hoc-Mitteilung gemäss Artikel 53 des Kotierungsreglements der SIX Exchange Regulation
REKORDRESULTATE FÜR UMSATZ, GELDFLUSS UND BEREINIGTEN EBIT
Ergebnisse 2023
Hong Kong Ferry Group Co-organised Anti-Deception Ferry “Ping On” Launching Ceremony and Harbour Cruise Tour
Hong Kong Ferry Group Co-organised Anti-Deception Ferry “Ping On” Launching Ceremony and Harbour Cruise Tour
Hong Kong Ferry Group Won “Top Ten Highest Volunteer Hours” Award Metro Harbour View Being “Top 10 Caring Estates”
Hong Kong Ferry Group Won “Top Ten Highest Volunteer Hours” Award Metro Harbour View Being “Top 10 Caring Estates”
The Royale Awarded Final Silver BEAM Plus Certification
The Royale Awarded Final Silver BEAM Plus Certification
Oriental Watch's (398.HK) Official Launch of TimeCare: Empowering Luxury Timepieces with Blockchain Insurance
Oriental Watch's (398.HK) Official Launch of TimeCare: Empowering Luxury Timepieces with Blockchain Insurance
Hang Seng mit Hang zur Trendwende!
Der Hang Seng Index (ISIN: HK0000004322), einer der führenden Aktienindices in Asien, notiert mittlerweile über 15 Prozent unter den Jahreshochs aus dem Januar 2018 bei....
EQS-News: Proposed Change of Company Name to Better Reflect Business Expansion Entering the Space of Bioscience with Renowned Science and Finance Expert on Board
EQS-News: Proposed Change of Company Name to Better Reflect Business Expansion Entering the Space of Bioscience with Renowned Science and Finance Expert on Board
EQS-News: Uni-Bio Science Group Limited 2019 Annual Results Turnover Increased by 54.9% YoY to HK$209.4 million Recording EBITDA of HK$28.4 million Achieved Significant Progress towards Pipeline Product with 2 Product Launches Expected in 2020
EQS-News: Uni-Bio Science Group Limited 2019 Annual Results Turnover Increased by 54.9% YoY to HK$209.4 million Recording EBITDA of HK$28.4 million Achieved Significant Progress towards Pipeline Product with 2 Product Launches Expected in 2020
EQS-News: Great Bay Bio injected with 2.5 million USD of convertible note
EQS-News: Great Bay Bio injected with 2.5 million USD of convertible note
EQS-News: Great Bay Bio and Boji Medical have Reached Strategic Cooperation to Jointly Develop a Long-Acting Biological and Innovative Anti-Anemia Injection
EQS-News: Great Bay Bio and Boji Medical have Reached Strategic Cooperation to Jointly Develop a Long-Acting Biological and Innovative Anti-Anemia Injection
Trio Industrial Electronics Group Limited Announces 2023 Annual Results
Trio Industrial Electronics Group Limited Announces 2023 Annual Results
Uni-Bio Science Group Announces 2023 Annual Results
Uni-Bio Science Group Announces 2023 Annual Results
Deltrix Kazakhstan Expands in Central Asia Joins Hands with CAMCE to Deepen Regional Cooperation Along The 'Belt and Road'
Deltrix Kazakhstan Expands in Central Asia Joins Hands with CAMCE to Deepen Regional Cooperation Along The 'Belt and Road'
Trio Group Joins Hands with Sinooil to Venture into Central Asian Markets Deltrix EV Chargers First Launched in Kazakhstan
Trio Group Joins Hands with Sinooil to Venture into Central Asian Markets Deltrix EV Chargers First Launched in Kazakhstan
Marketing application of Diquafosol Sodium eye drops has been officially accepted by the China National Medical Products Administration (NMPA)
Marketing application of Diquafosol Sodium eye drops has been officially accepted by the China National Medical Products Administration (NMPA)
As A Breakthrough Drug For The Expansive Osteoporosis Market, Bogutai® (Teriparatide Injection) Has Been Officially Approved By The China National Medical Products Administration (NMPA)
As A Breakthrough Drug For The Expansive Osteoporosis Market, Bogutai® (Teriparatide Injection) Has Been Officially Approved By The China National Medical Products Administration (NMPA)
Uni-Bio Science Group Limited Announces 2023 Interim Results
Uni-Bio Science Group Limited Announces 2023 Interim Results
Uni-Bio Science Group Limited: 2022 Annual Results
Uni-Bio Science Group Limited: 2022 Annual Results
Uni-Bio Science Group Limited: 2022 Interim Results
Uni-Bio Science Group Limited: 2022 Interim Results
EQS-News: Marketing application of BOGUTAI® (teriparatide injection) has been officially accepted by the China National Medical Products Administration (NMPA)
EQS-News: Marketing application of BOGUTAI® (teriparatide injection) has been officially accepted by the China National Medical Products Administration (NMPA)
EQS-News: Uni-Bio Science Group Limited：2021 Annual Results
EQS-News: Uni-Bio Science Group Limited：2021 Annual Results
Smith & Wesson, A Timeless Value Play At Decade Lows
Key Points
- Shares of Smith & Wesson are popping in the after-market hours of Thursday evening as the company reports its quarterly earnings results. Despite some disappointing figures, other
Understanding Workers’ Compensation Insurance For Independent Contractors
Workers’ compensation insurance is essential coverage that protects employees and their families financially if a worker is injured or killed on the job. Also called workers’ comp and workman’s
Beware The TikTok Trojan Horse
The truth behind the TikTok hearing… Your vacuum cleaner could be spying on you… Two words that make every American a suspect… This is what concerns me the most…
Wave Goodbye To Your Right To